192 related articles for article (PubMed ID: 38355645)
21. Association between human papillomavirus and Epstein - Barr virus DNA and gene promoter methylation of RB1 and CDH1 in the cervical lesions: a transversal study.
McCormick TM; Canedo NH; Furtado YL; Silveira FA; de Lima RJ; Rosman AD; Almeida Filho GL; Carvalho Mda G
Diagn Pathol; 2015 Jun; 10():59. PubMed ID: 26032781
[TBL] [Abstract][Full Text] [Related]
22. DNA methylation patterns of ulcer-healing genes associated with the normal gastric mucosa of gastric cancers.
Hong SJ; Oh JH; Jung YC; Kim YH; Kim SJ; Kang SJ; Seo EJ; Choi SW; Kang MI; Rhyu MG
J Korean Med Sci; 2010 Mar; 25(3):405-17. PubMed ID: 20191040
[TBL] [Abstract][Full Text] [Related]
23. [Hypermethylation of the CDH1, SEPT9, HLTF and ALX4 genes and their diagnostic significance in colorectal cancer].
Kostin PA; Zakharzhevskaia NB; Generozov EV; Govorun VM; Chernyshov SV; Shchelygin IuA
Vopr Onkol; 2010; 56(2):162-8. PubMed ID: 20552891
[TBL] [Abstract][Full Text] [Related]
24. CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer.
Caldeira JR; Prando EC; Quevedo FC; Neto FA; Rainho CA; Rogatto SR
BMC Cancer; 2006 Mar; 6():48. PubMed ID: 16512896
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia.
Zou D; Yoon HS; Perez D; Weeks RJ; Guilford P; Humar B
J Pathol; 2009 Jun; 218(2):265-72. PubMed ID: 19294736
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic silencing of genes enhanced by collective role of reactive oxygen species and MAPK signaling downstream ERK/Snail axis: Ectopic application of hydrogen peroxide repress CDH1 gene by enhanced DNA methyltransferase activity in human breast cancer.
Pradhan N; Parbin S; Kar S; Das L; Kirtana R; Suma Seshadri G; Sengupta D; Deb M; Kausar C; Patra SK
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1651-1665. PubMed ID: 30954555
[TBL] [Abstract][Full Text] [Related]
27. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.
Bustos-Carpinteyro AR; Oliveira C; Sousa A; Oliveira P; Pinheiro H; Carvalho J; Magaña-Torres MT; Flores-Miramontes MG; Aguilar-Lemarroy A; Jave-Suárez LF; Peregrina-Sandoval J; Cruz-Ramos JA; Sánchez-López JY
BMC Cancer; 2019 Jan; 19(1):69. PubMed ID: 30642281
[TBL] [Abstract][Full Text] [Related]
28. [CpG island methylation of E-cadherin gene promoter in gastric carcinoma].
Zhou YN; Xu CP; Han B; Ji R
Ai Zheng; 2005 Oct; 24(10):1220-4. PubMed ID: 16219136
[TBL] [Abstract][Full Text] [Related]
29. Association of clinicopathological features with E-cadherin (CDH1) gene-160 C>A promoter polymorphism in Turkish colorectal cancer patients.
Bahadir A; Eral G; Budak M; Shimamoto F; Korpinar MA; Erdamar S; Tuncel H
J Cancer Res Ther; 2019; 15(1):26-31. PubMed ID: 30880750
[TBL] [Abstract][Full Text] [Related]
30. Correction: Increased CpG methylation at the CDH1 locus in inflamed ileal mucosa of patients with Crohn disease.
de Ponthaud C; Abdalla S; Belot MP; Shao X; Penna C; Brouquet A; Bougnères P
Clin Epigenetics; 2024 Mar; 16(1):43. PubMed ID: 38500164
[No Abstract] [Full Text] [Related]
31. Loss of expression and aberrant methylation of the CDH1 (E-cadherin) gene in breast cancer patients from Kashmir.
Asiaf A; Ahmad ST; Aziz SA; Malik AA; Rasool Z; Masood A; Zargar MA
Asian Pac J Cancer Prev; 2014; 15(15):6397-403. PubMed ID: 25124632
[TBL] [Abstract][Full Text] [Related]
32. Association of genetic variants in and promoter hypermethylation of CDH1 with gastric cancer: a meta-analysis.
Jing H; Dai F; Zhao C; Yang J; Li L; Kota P; Mao L; Xiang K; Zheng C; Yang J
Medicine (Baltimore); 2014 Oct; 93(19):e107. PubMed ID: 25340495
[TBL] [Abstract][Full Text] [Related]
33. Predicting cervical intraepithelial neoplasia recurrence in HIV-infected and -noninfected women by detecting aberrant promoter methylation in the CDH1, TIMP3, and MGMT genes.
Teixeira da Costa Lodi C; Michelin MA; Miranda Lima MI; Murta EFC; Braga LDC; Montes L; Melo VH
Arch Gynecol Obstet; 2018 Nov; 298(5):971-979. PubMed ID: 30218185
[TBL] [Abstract][Full Text] [Related]
34. Diet-induced hypoxia responsive element demethylation increases CEACAM6 expression, favouring Crohn's disease-associated Escherichia coli colonisation.
Denizot J; Desrichard A; Agus A; Uhrhammer N; Dreux N; Vouret-Craviari V; Hofman P; Darfeuille-Michaud A; Barnich N
Gut; 2015 Mar; 64(3):428-37. PubMed ID: 24898815
[TBL] [Abstract][Full Text] [Related]
35. Disordered beta-catenin expression and E-cadherin/CDH1 promoter methylation in gastric carcinoma.
Wang L; Zhang F; Wu PP; Jiang XC; Zheng L; Yu YY
World J Gastroenterol; 2006 Jul; 12(26):4228-31. PubMed ID: 16830381
[TBL] [Abstract][Full Text] [Related]
36. Retrospective protein expression and epigenetic inactivation studies of CDH1 in patients affected by low-grade glioma.
D'Urso PI; D'Urso OF; Storelli C; Catapano G; Gianfreda CD; Montinaro A; Muscella A; Marsigliante S
J Neurooncol; 2011 Aug; 104(1):113-8. PubMed ID: 21127944
[TBL] [Abstract][Full Text] [Related]
37. Aberrant CpG island hypermethylation in pediatric gastric mucosa in association with Helicobacter pylori infection.
Shin SH; Park SY; Ko JS; Kim N; Kang GH
Arch Pathol Lab Med; 2011 Jun; 135(6):759-65. PubMed ID: 21631269
[TBL] [Abstract][Full Text] [Related]
38. Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas.
Qian ZR; Sano T; Yoshimoto K; Asa SL; Yamada S; Mizusawa N; Kudo E
Mod Pathol; 2007 Dec; 20(12):1269-77. PubMed ID: 17873891
[TBL] [Abstract][Full Text] [Related]
39. Quantitative profiling of CpG island methylation in human stool for colorectal cancer detection.
Elliott GO; Johnson IT; Scarll J; Dainty J; Williams EA; Garg D; Coupe A; Bradburn DM; Mathers JC; Belshaw NJ
Int J Colorectal Dis; 2013 Jan; 28(1):35-42. PubMed ID: 22791128
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of E-cadherin expression in breast cancer by promoter hypermethylation and its relation with progression and prognosis of tumor.
Shargh SA; Sakizli M; Khalaj V; Movafagh A; Yazdi H; Hagigatjou E; Sayad A; Mansouri N; Mortazavi-Tabatabaei SA; Khorram Khorshid HR
Med Oncol; 2014 Nov; 31(11):250. PubMed ID: 25260805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]